Big-data study pinpoints more than 150 genes associated with atrial fibrillation

August 2, 2018, University of Michigan
A 12 lead ECG showing atrial fibrillation at approximately 150 beats per minute. Credit: James Heilman, MD/Wikipedia/CC BY-SA 3.0

Drawing on genomic data from more than one million individuals, researchers from the University of Michigan have led a large collaborative effort to discover as-yet unknown genetic risk factors for atrial fibrillation: an irregular, often rapid heart rate affecting millions of Americans and more than 30 million people worldwide. Atrial fibrillation increases one's risk for blood clots, stroke, heart failure, and death.

By performing one large genome-wide association study (GWAS) comprising data from six smaller studies, scientists identified 151 candidate genes for atrial fibrillation. Many of the genes identified are important for fetal development of the heart, implying that genetic variation predisposes the heart to atrial fibrillation during fetal development, or, that the genetic variation could reactivate genes in the adult heart that normally only function during fetal development.

The results of the study have been published in Nature Genetics ("Biobank-driven genomic discovery yields new insight into atrial fibrillation biology").

The increased understanding the study yields of the biological processes underlying atrial fibrillation could lead to better treatment and prevention. "We are hopeful that additional molecular biology experiments will determine how to create sustained regular heart rhythms by studying the genes we and others have identified," said study author Cristen Willer, Ph.D., associate professor at Michigan Medicine and head of U-M's Willer lab.

If atrial fibrillation is detected early, it is possible to prevent complications such as stroke and failure. Current treatment options for atrial fibrillation are limited, however, include serious side effects, and are rarely curative. The genetic variants uncovered in this study could potentially improve both early detection and treatment. By identifying genes important for atrial fibrillation, researchers constructed a risk score to help identify high-risk individuals and monitor them accordingly, which "may have important implications for precision health and prevention of cardiovascular disease," said Willer.

Of the 151 genes identified as important for atrial fibrillation, 32 are likely to interact with existing drugs not necessarily developed to treat atrial fibrillation. This study lays the groundwork for follow-up experiments to test whether any of the identified drugs could prevent or terminate atrial fibrillation.

This study used data from multiple biobanks from around the world, including UM's Michigan Genomics Initiative (MGI), UK Biobank, Norway's HUNT study, DiscovEHR, Iceland's deCODE Genetics, and AFGen Consortium. This big-data, precision-health approach yielded insights that may not have been discoverable using a smaller dataset.

"Discovery of novel genetic variants and important for atrial fibrillation was only possible because we combined information from multiple biobanks from around the world in a large collaborative effort," said first author Jonas Bille Nielsen, M.D., Ph.D., a cardiovascular researcher at U-M. "Combining the advantages of each of the data sources helped us to better understand the biology underlying atrial fibrillation [and]... revealed the risk score we constructed is very specific for atrial fibrillation. By combining multiple independent data sources, we also found that people with early-onset atrial fibrillation have a higher genetic burden of atrial fibrillation compared with people who develop the disease later in life."

The study's researchers acknowledge that their findings, while significant, need further confirmation, but are hopeful that this work will form the foundation for future experiments to understand the biology behind , and to identify tailored, more effective treatment options for the condition.

"As scientists, we need to continue to focus on the goal—helping patients with cardiovascular disease—and collaborate toward that goal," said Willer. "That's exactly what happened here, with the additional benefit of helping train the next generation of cardiovascular geneticists, like first author Jonas Nielsen."

Explore further: Patients who have had an irregular heart beat can't ever be considered 'cured'

More information: Jonas B. Nielsen et al, Biobank-driven genomic discovery yields new insight into atrial fibrillation biology, Nature Genetics (2018). DOI: 10.1038/s41588-018-0171-3

Related Stories

Patients who have had an irregular heart beat can't ever be considered 'cured'

May 10, 2018
Patients with an abnormal heart rhythm that can leave them at a higher risk of suffering from stroke still need treatment even after their heart rhythm seems to have returned to normal, say researchers at the University of ...

Obesity might raise your risk for A-fib

May 9, 2018
(HealthDay)—Obese people are at increased risk for the heart rhythm disorder atrial fibrillation, which can cause complications such as heart failure and stroke.

Atrial fibrillation risk rises with decreasing kidney function

August 10, 2017
A new study indicates that individuals with kidney disease have a higher risk of developing atrial fibrillation, or an irregular heartbeat. The findings, which appear in an upcoming issue of the Clinical Journal of the American ...

To have or not to have... your left atrial appendage closed

May 22, 2018
Each year in the U.S., more than 300,000 people have heart surgery. To reduce risk of stroke for their patients, surgeons often will close the left atrial appendage, which is a small sac in the left side of the heart where ...

Smoking, alcohol consumption increase lifetime risk of atrial fibrillation

April 30, 2018
Lifetime risk is a useful method to quantify risk of atrial fibrillation over a person's lifetime. However, data are scarce with respect to the lifetime risk of atrial fibrillation in the presence of one or multiple risk ...

Recommended for you

Genetic link discovered between circadian rhythms and mood disorders

August 15, 2018
Circadian rhythms are regular 24-hour variations in behaviour and activity that control many aspects of our lives, from hormone levels to sleeping and eating habits.

Ovarian cancer genetics unravelled

August 14, 2018
Patterns of genetic mutation in ovarian cancer are helping make sense of the disease, and could be used to personalise treatment in future.

New genome-editing strategy could lead to therapeutics

August 14, 2018
Researchers at UMass Medical School have developed a genome-editing strategy to correct disease-causing DNA mutations in mouse models of human genetic diseases, according to research published in the Aug. 18 edition of Nature ...

Study reveals broad 'genetic architectures' of traits and diseases

August 13, 2018
Scientists at Johns Hopkins Bloomberg School of Public Health have developed a powerful method for characterizing the broad patterns of genetic contributions to traits and diseases. The new method provides a "big picture" ...

Genetic tools uncover cause of childhood seizure disorder missed by other methods

August 13, 2018
Early childhood seizures result from a rare disease that begin in the first months of life. Researchers at University of Utah Health have developed high-tech tools to uncover the genetic cause of the most difficult to diagnose ...

Researchers predict risk for common deadly diseases from millions of genetic variants

August 13, 2018
A research team at the Broad Institute of MIT and Harvard, Massachusetts General Hospital (MGH), and Harvard Medical School reports a new kind of genome analysis that could identify large fractions of the population who have ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.